mittyri ★★ Russia, 2013-11-01 09:30 (4208 d 09:13 ago) Posting: # 11854 Views: 10,121 |
|
Dear All, I would ask you about the concentration/time curve in capecitabine study. Here's an example from M. Mackean et al. "Phase I and Pharmacologic Study of Intermittent Twice-Daily Oral Therapy With Capecitabine in Patients With Advanced and/or Metastatic Cancer" Journal of Clinical Oncology, Vol 16, No 9, 1998: pp 2977-2985 ![]() As you can see capecitabine and 5-FU curves have 2 slopes. What is the reason of such curve shapes? fed condition or something else? In our study we have similar results. Edit: Category changed. [Helmut] — Kind regards, Mittyri |
Helmut ★★★ ![]() ![]() Vienna, Austria, 2013-11-01 16:11 (4208 d 02:32 ago) @ mittyri Posting: # 11856 Views: 8,267 |
|
Hi Miityri, ❝ As you can see capecitabine and 5-FU curves have 2 slopes. What is the reason of such curve shapes? Capecitabine is partly excreted unchanged into the bile and known to undergo enterohepatic recirculation; such profiles are common. Capecitabine → 5’-dFCR → 5’-dFUR → 5-FU → DHFU → FUPA → FBAL Note that the primary metabolite 5’-dFCR does not show first-order elimination between 1–4 hours as well (concave semilog-plot). Cmax of the secondary 5’-dFUR is actually due to the reabsorbed fraction. If you walk the metabolization-chain further ‘downstream’ peaks merge and are shifted to later times.❝ fed condition or something else? See above – but in fasting state you would see a shift of the second peak towards later times (emptying of the gall bladder triggered by food). However, administration after food is the labeled use of Xeloda. ❝ In our study we have similar results. As expected. Nothing to worry about in BE (that’s the drug, not the formulation). — Dif-tor heh smusma 🖖🏼 Довге життя Україна! ![]() Helmut Schütz ![]() The quality of responses received is directly proportional to the quality of the question asked. 🚮 Science Quotes |
mittyri ★★ Russia, 2013-11-21 13:23 (4188 d 05:20 ago) @ Helmut Posting: # 11934 Views: 6,364 |
|
Hi Helmut, Thank you for exhaustive explanation! The information from this forum is very helpful. I've one more question following up upon this topic. One of the subjects has actual data: ![]() All points are BQL after last visible point. So the question is: how to calculate the AUC part from tlast to infinity in this case with Winnonlin (what kind of points to collect for lambda z calculation & hl)? — Kind regards, Mittyri |
Helmut ★★★ ![]() ![]() Vienna, Austria, 2013-11-21 15:18 (4188 d 03:25 ago) @ mittyri Posting: # 11936 Views: 6,912 |
|
Hi Mittyri, ❝ So the question is: how to calculate the AUC part from tlast to infinity in this case with Winnonlin (what kind of points to collect for lambda z calculation & hl)? What did you state in the protocol?
— Dif-tor heh smusma 🖖🏼 Довге життя Україна! ![]() Helmut Schütz ![]() The quality of responses received is directly proportional to the quality of the question asked. 🚮 Science Quotes |
mittyri ★★ Russia, 2013-11-22 09:25 (4187 d 09:18 ago) @ Helmut Posting: # 11941 Views: 6,266 |
|
Hi Helmut, Thank you for advice! ❝ What did you state in the protocol? I didn't state in the protocol anything about this situation. Now I have a plan&experience ![]() Could you give a cue in the same situation: ![]() Last point is BLQ. What do you think about this case? How to calculate λz? — Kind regards, Mittyri |